Brief: Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement With Innoviva
04/03/2024 21:04
March 4 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES $35 MILLION SECURED
CREDIT
AGREEMENT WITH INNOVIVA
* ARMATA PHARMACEUTICALS- PROCEEDS FROM NEW FINANCING TO BE
USED
TO ADVANCE CO'S LEAD THERAPEUTIC PHAGE CANDIDATES, INCLUDING
AP‐PA02 AND AP‐SA02
Source text for Eikon: ID:nPnsdsTya
Further company coverage: ARMP.A
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million